Analysts Set Nutrien Ltd. (NYSE:NTR) Target Price at $62.65

Key Points

• Nutrien Ltd. has received a consensus rating of "Moderate Buy" from eighteen analysts, with the average one-year price target set at $62.65.
• The company reported $2.65 earnings per share for the last quarter, surpassing analysts' expectations by $0.24, and had a revenue of $10.30 billion.
• Nutrien announced a quarterly dividend of $0.545, totaling an annualized dividend of $2.18 and yielding 3.8%.

Nutrien Ltd. (NYSE:NTR - Get Free Report) has been given a consensus rating of "Hold" by the twenty ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, six have given a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $62.3889.

Several brokerages have recently weighed in on NTR. Royal Bank Of Canada reiterated an "outperform" rating on shares of Nutrien in a report on Monday, July 14th. Raymond James Financial lowered shares of Nutrien from an "outperform" rating to a "market perform" rating and set a $68.00 price target on the stock. in a report on Tuesday, June 17th. Bank of America raised their price target on shares of Nutrien from $60.00 to $63.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Wells Fargo & Company raised their price target on shares of Nutrien from $59.00 to $62.00 and gave the company an "equal weight" rating in a report on Thursday, July 17th. Finally, Barclays raised their price target on shares of Nutrien from $61.00 to $64.00 and gave the company an "equal weight" rating in a report on Monday, July 7th.

Nutrien Trading Up 1.7%

Shares of NTR stock traded up $0.95 during trading hours on Friday, hitting $57.40. 2,399,973 shares of the company were exchanged, compared to its average volume of 2,042,758. The firm has a market cap of $27.90 billion, a PE ratio of 20.57, a PEG ratio of 0.95 and a beta of 0.77. Nutrien has a 1 year low of $43.69 and a 1 year high of $65.08. The company has a quick ratio of 0.85, a current ratio of 1.33 and a debt-to-equity ratio of 0.39. The firm has a fifty day moving average of $58.54 and a 200 day moving average of $56.22.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $2.65 earnings per share for the quarter, topping the consensus estimate of $2.41 by $0.24. The business had revenue of $10.30 billion for the quarter, compared to analyst estimates of $10.40 billion. Nutrien had a net margin of 5.25% and a return on equity of 6.51%. The company's revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.34 EPS. Analysts expect that Nutrien will post 3.72 earnings per share for the current year.

Nutrien Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Monday, September 29th will be issued a $0.545 dividend. The ex-dividend date is Monday, September 29th. This represents a $2.18 annualized dividend and a yield of 3.8%. Nutrien's dividend payout ratio (DPR) is presently 78.14%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. Northern Trust Corp raised its stake in shares of Nutrien by 59.3% during the fourth quarter. Northern Trust Corp now owns 356,031 shares of the company's stock valued at $15,932,000 after purchasing an additional 132,601 shares during the period. Aptus Capital Advisors LLC purchased a new stake in shares of Nutrien during the fourth quarter valued at approximately $511,000. Bank of America Corp DE raised its stake in shares of Nutrien by 5.9% during the fourth quarter. Bank of America Corp DE now owns 2,685,886 shares of the company's stock valued at $120,193,000 after purchasing an additional 150,464 shares during the period. Bayesian Capital Management LP purchased a new stake in shares of Nutrien during the fourth quarter valued at approximately $201,000. Finally, Balyasny Asset Management L.P. raised its stake in shares of Nutrien by 93.4% during the fourth quarter. Balyasny Asset Management L.P. now owns 17,995 shares of the company's stock valued at $805,000 after purchasing an additional 8,690 shares during the period. Hedge funds and other institutional investors own 63.10% of the company's stock.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.